BNGO - Bionano Genomics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
29.67M
Enterprise Value 3
40.38M
Trailing P/E
N/A
Forward P/E 1
-1.78
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
2.61
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
3.56
Enterprise Value/EBITDA 6
-1.69

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-83.23%
S&P500 52-Week Change 318.19%
52 Week High 38.0000
52 Week Low 30.5000
50-Day Moving Average 30.9530
200-Day Moving Average 31.7117

Share Statistics

Avg Vol (3 month) 35.36M
Avg Vol (10 day) 36.46M
Shares Outstanding 526.49M
Float 21.1M
% Held by Insiders 116.20%
% Held by Institutions 124.57%
Shares Short (Nov 15, 2019) 42.86M
Short Ratio (Nov 15, 2019) 40.23
Short % of Float (Nov 15, 2019) 440.24%
Short % of Shares Outstanding (Nov 15, 2019) 410.80%
Shares Short (prior month Oct 15, 2019) 4204k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin -249.48%
Operating Margin (ttm)-218.54%

Management Effectiveness

Return on Assets (ttm)-62.19%
Return on Equity (ttm)-721.08%

Income Statement

Revenue (ttm)11.35M
Revenue Per Share (ttm)1.08
Quarterly Revenue Growth (yoy)17.10%
Gross Profit (ttm)3.29M
EBITDA -23.85M
Net Income Avi to Common (ttm)-28.33M
Diluted EPS (ttm)-2.6940
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.22M
Total Cash Per Share (mrq)0.31
Total Debt (mrq)19.73M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.40
Book Value Per Share (mrq)-0.68

Cash Flow Statement

Operating Cash Flow (ttm)-24.14M
Levered Free Cash Flow (ttm)-13.66M